Skip to content

Anxiety: all studies

Page 210 of 773: studies 2,091 to 2,100 of 7,721, newest first. Back to the anxiety overview

Research

Exploring the Physiological and Psychological Effects of Group Chanting in Australia: Reduced Stress, Cortisol and Enhanced Social Connection.

Journal of Religion and Health December 1, 2024 Gemma Perry, Vince Polito, William Forde Thompson 17 citations

Chanting, an ancient ritual practiced in diverse cultures and traditions worldwide, has typically been employed for meditation, healing, self-awareness, and psychological growth. However, there is little understanding of the physiological and psychological benefits of chanting, and how vocalization might contribute to such effects. This study aimed to determine whether 12-minutes of group...

A Randomized Controlled Trial of Mindfulness Meditation Combined With BrainLink Intelligent Biofeedback Instrument on Pancreatic Cancer Patients Under Chemotherapy.

Brain and Behavior December 1, 2024 Na Mi, Shu-Ting Zhang, Xiao-Li Sun et al. 5 citations

Adjuvant chemotherapy can promote the 5-year overall survival rate of pancreatic cancer (PC) patients to 16%-21%. However, the negative emotions of patients, such as anxiety, are usually omitted. Moreover, their disease burden concentrates on pain symptoms, seriously affecting the quality of life of patients. How to improve the negative emotions of PC patients, alleviate their pain, and...

Mindfulness-based intervention as a symptom management strategy in patients with end-stage renal disease: A controlled clinical trial.

International Journal of Nursing Practice December 1, 2024 Hossam Alhawatmeh, Ishraq A. Najadat, Issa M. Hweidi

The study's purpose was to examine the effect of mindfulness-based intervention (MBI) on physical and psychological symptoms in patients with end-stage renal disease (ESRD) in Jordan. A repeated-measure randomized control study was conducted in a haemodialysis unit in Jordan between April 2023 and July 2023. Participants (N = 61) were selected using convenience sampling and then randomly...

A Preliminary Evaluation of the Feasibility and Efficacy of Mantra-Like Phrase Recitation in Improving Mental Health in Autistic Adults.

Advances in neurodevelopmental disorders December 1, 2024 Rachel C Corney, Rose E Nevill, Micah O Mazurek 3 citations

Mantra recitation has been shown to improve emotional well-being in neurotypical individuals with mental health conditions; however, no research has explored its effect on the autistic population. The private, routine nature of mantra and mantra-like recitation may offer unique advantages for autistic individuals struggling with negative emotions and emotion regulation. The purpose of this...

Ketamine modulates the exploratory dynamics and homebase-related behaviors of adult zebrafish.

Pharmacology, Biochemistry, and Behavior December 1, 2024 Camilla W Pretzel, João V Borba, Cássio M Resmim et al. 5 citations

Anxiety can be a protective emotion when animals face aversive conditions, but is commonly associated with various neuropsychiatric disorders when pathologically exacerbated. Drug repurposing has emerged as a valuable strategy based on utilizing the existing pharmaceuticals for new therapeutic purposes. Ketamine, traditionally used as an anesthetic, acts as a non-competitive antagonist of the...

DOI: 10.1016/j.pbb.2024.173892 (opens in new tab) Full text (opens in new tab) Nmda receptor Open field test Spatio-temporal exploration Stereotyped behavior +6

Pharmacotherapeutic strategies for the treatment of anorexia nervosa - novel targets to break a vicious cycle.

Expert Opinion on Pharmacotherapy December 1, 2024 Millie C Kirchberg, Claire Pinson, Guido K W Frank 9 citations

Anorexia nervosa (AN) has one of the highest mortality rates of all mental illnesses. No approved pharmacological treatments exist for AN, but novel neurobiological targets show promise. Studies show that in individuals with AN, there are alterations in brain neurotransmitter signaling, alongside associated mental rigidity and comorbid anxiety and depression. Available and new therapies could...

The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges.

CNS Spectrums December 1, 2024 Mauro Scala, Chiara Fabbri, Paolo Fusar‐poli et al. 8 citations

The revival of psilocybin in psychopharmacological research heralds a potential paradigm shift for treating mood and anxiety disorders, and other psychiatric conditions beyond the psychotic spectrum. This critical review evaluates current evidence on psilocybin's efficacy, juxtaposing potential benefits with the practical aspects of psychedelic-assisted psychotherapy (PAP) and the...

Behavioural Effects of High Doses of Psilocybin in Female Rats

November 21, 2024 Larissa Rocha

<p><strong>Depression and anxiety are two of the most predominant mental disorders and leading causes of disability. The World Health Organization estimated that 3.8% of the world's population suffers from depression, and between 0.4% and 3.6% have an anxiety spectrum diagnosis. Psychedelics, particularly psilocybin, have been extensively studied as new and promising treatments, showing...

Ventral hippocampal parvalbumin interneurons gate the acute anxiolytic action of the serotonergic psychedelic DOI.

Neuron November 20, 2024 Praachi Tiwari, Pasha A. Davoudian, Darshana Kapri et al. 26 citations

There has been a recent renewal of interest in the therapeutic potential of serotonergic psychedelics. Here, we uncover the essential role of ventral hippocampus (vHpc) GABAergic interneurons in the anxiolytic effect evoked by the serotonergic psychedelic 2,5-dimethoxy-4-iodoamphetamine (DOI). Integrating anatomical, pharmacological, and genetic approaches, we show that 5-HT2A receptors in the...

Ketamine-induced altered states of consciousness: a systematic review of implications for therapeutic outcomes in psychiatric practices.

European Archives of Psychiatry and Clinical Neuroscience October 28, 2024 Kaike Thiê da Costa Gonçalves, Vagner Deuel O de Tavares, Maria Luiza de Morais Barros et al. 5 citations

This systematic review aims to elucidate the nexus between ketamine's psychoactive properties and its efficacy in treating a broad spectrum of psychiatric disorders. We searched three databases and used citation tracking to include 29 studies. Predominantly, mood disorders, including bipolar disorder (BD) and major depressive disorder (MDD) (MDD + BD: + n = 25 studies), a large part of them...